ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $28,045,000 | -18.8% | 11,246,000 | +21.6% | 0.82% | -13.1% |
| Q4 2015 | $34,551,000 | +45.1% | 9,246,000 | -5.0% | 0.94% | -11.5% |
| Q3 2015 | $23,809,000 | -5.2% | 9,728,000 | +34.6% | 1.06% | -2.0% |
| Q2 2015 | $25,104,000 | -46.6% | 7,228,000 | -40.9% | 1.09% | -40.2% |
| Q1 2015 | $46,971,000 | -30.9% | 12,228,000 | -32.9% | 1.82% | -33.2% |
| Q4 2014 | $67,928,000 | +54.2% | 18,228,000 | 0.0% | 2.72% | +59.0% |
| Q3 2014 | $44,066,000 | +1.5% | 18,228,000 | -7.6% | 1.71% | -0.2% |
| Q2 2014 | $43,426,000 | +15.8% | 19,728,000 | +41.1% | 1.71% | +7.1% |
| Q1 2014 | $37,505,000 | -11.8% | 13,978,000 | -18.2% | 1.60% | -14.3% |
| Q4 2013 | $42,505,000 | +416.3% | 17,096,000 | +388.5% | 1.87% | +330.0% |
| Q3 2013 | $8,232,000 | – | 3,500,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fore Research & Management, LP | 45,073,000 | $109,189,000 | 3.21% |
| WHITEBOX ADVISORS LLC | 18,228,000 | $44,066,000 | 1.71% |
| Nantahala Capital Management | 5,650,000 | $13,765,000 | 1.69% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 5,800,000 | $14,022,000 | 1.43% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,720,000 | $62,292,000 | 1.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 13,000,000 | $31,560,000 | 0.36% |
| CSS LLC/IL | 2,534,000 | $6,139,000 | 0.30% |
| LORD, ABBETT & CO. LLC | 17,349,000 | $42,028,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,300,000 | $3,153,000 | 0.08% |
| Citadel Advisors | 24,500,000 | $59,352,000 | 0.06% |